Baylor Health Care System
 
2 4 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Leishmaniasis

Alternative Names

Kala-azar

Treatment

Medicines called antimony-containing compounds are the main drugs used to treat leishmaniasis. These include:

  • Meglumine antimonate
  • Sodium stibogluconate

Other drugs that may be used include:

  • Amphotericin B
  • Pentamidine

Plastic surgery may be needed to correct disfigurement by destructive facial lesions (cutaneous leishmaniasis). Removal of the spleen (splenectomy) may be required in drug-resistant cases of visceral leishmaniasis.

Outlook (Prognosis)

Cure rates are high with the proper medicine. Treatment should be received before damage to the immune system occurs. Cutaneous leishmaniasis may lead to disfiguration.

Death usually results from complications (such as other infections) rather than from the disease itself. Death often occurs within 2 years.

Possible Complications

  • Deadly infections due to immune system damage
  • Disfiguration of the face
  • Hemorrhage (bleeding)

When to Contact a Medical Professional

Contact your health care provider if you have symptoms of leishmaniasis after visiting an area where the disease is known to occur.

References

Reithinger R. Cutaneous leishmaniasis. Lancet Infect Dis. Sep 2007; 7(9): 581-96.

Review Date: 10/30/2007
Reviewed By: David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission. URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2005 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.